Description
Urinary stoneosis is a pathological condition that results from the deposition of crystals in the urinary tract due to the precipitation and aggregation of dissolved substances in urine.
This may be due to changes in the degree of saturation of the urine itself (due to an increase in the concentration of certain compounds), changes in urinary pH or the reduction of certain substances that physiologically inhibit crystallisation (particularly citrates).
Calcomann is an innovative nutraceutical formulation that contributes, thanks to the synergic action of its 4 components, to the dissolution of urinary calculi, while promoting their excretion.
- It affects 20% of the population
- Relapses: 50% of cases
- Lithotripsy = extracorporeal shock wave fragmentation
- ESWL=Electro shock wave litotripsy
- BPH is a complication for obstruction and vice versa
- They affect 12% of males and 40% of females
- Relapses: 50% of cases
- Target: E. coli in 80-90% of cases
- BPH is complication for UTI